ATAI is AtaiBeckley Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $7.39. Market cap: $2.74B.
Stock snapshot
| Price | $7.39 |
| Market cap | $2.74B |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
About ATAI
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Related non-dividend companies
Other non-dividend stocks investors research alongside ATAI. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is ATAI's current stock price?
ATAI (AtaiBeckley Inc. Common Stock) is currently trading at $7.39.
Does ATAI pay a dividend?
ATAI (AtaiBeckley Inc. Common Stock) does not currently pay a regular dividend.
Track ATAI in DiviDrip
Add ATAI to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search ATAI and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.